Reprint
Novel Approaches for Overcoming Biological Barriers
Edited by
May 2023
270 pages
- ISBN978-3-0365-7699-2 (Hardback)
- ISBN978-3-0365-7698-5 (PDF)
This book is a reprint of the Special Issue Novel Approaches for Overcoming Biological Barriers that was published in
Biology & Life Sciences
Chemistry & Materials Science
Medicine & Pharmacology
Summary
The human body poses various biological barriers to protect itself from pathogens, foreign materials and is important for its functioning and development. This reprint serves as a collection of research and review articles describing novel approaches and new therapeutic modalities to overcome biological barriers. This collection is a must read for scientists working in the field of drug and vaccine delivery.
Format
- Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
blood-brain barrier; integrity marker; sorbitol; positron emission tomography; focused ultrasound; zolmitriptan; intranasal; bilosomes; sodium deoxycholate; mucoadhesive gel; brain targeting; blood–brain barrier; drug formulation; drug hybrids; intra-arterial delivery; intracranial malignancies; intranasal delivery; monoterpene; monoterpenoid; NEO100; carbomer hydrogel; whitening agents; enhancers; enhancement site and mechanism; drug release and permeation; inhaled drug delivery; prodrug; liposome formulation; propofol; micelle; DSPE mPEG2k; Solutol HS 15; bilosomes; diclofenac; optimization; pharmacokinetic; pharmacodynamic study; long acting; sustained delivery; biologics; silica microparticles; exosome; brain delivery; BBB crossing; transcytosis; peptide-drug conjugates; blood–brain barrier; blood–placental barrier; Zika virus; BBB shuttles; porphyrins; antivirals; epidermal growth factor receptor; non-small cell lung cancer; Lamin B2; AMPK; Osimertinib; RNA seq; proteomics; RT-PCR; blood–brain tumor barrier; permeabilization; brain tumors; primary central nervous system lymphoma; tumor necrosis factor-alpha; targeted delivery; vascular targeting; CD13; TNF; TNF receptors; NGR-TNF; polyamidoamine dendrimers; diabetic retinopathy; protein kinase C-β inhibitor; nanoparticles; ruboxistaurin; blood brain barrier; electropermanent magnet; magnetic resonance imaging; n/a